Results 101 to 110 of about 191,709 (318)

Fabricating and Properties of Rifampicin-loaded Ethyl Cellulose Composites Via Electrospray

Studia Universitatis Babes-Bolyai Chemia
Rifampin (Rif) is usually applied as first-line anti-tubercular drugs but has limited bioavailability. Herein, Rif-loaded ethyl cellulose (EC) composites was designed and fabricated by electrospray to improve therapy effectiveness and duration.
Xi LI, Yanwen CHEN, Hong LI, Jiahao DING, Ya WANG, Jin MO, Mi ZHOU, Yaning LI, Qiuhan LIN, Boliang WANG   +9 more
doaj   +1 more source

Antileprotic medication induced psychosis in a patient of tuberous sclerosis: A case report

Indian Journal of Community and Family Medicine, 2017
Tuberous sclerosis is a rare multisystem neurocutaneous genetic disorder primarily presented with seizures, mental retardation and hamartomas involving multiple systems.
Udit Kumar Panda, Manas Ranjan Sahoo, Subhankar Swain   +2 more
doaj   +1 more source

Compounding Effects of Climate Warming and Antibiotic Resistance. [PDF]

, 2020
Bacteria have evolved diverse mechanisms to survive environments with antibiotics. Temperature is both a key factor that affects the survival of bacteria in the presence of antibiotics and an environmental trait that is drastically increasing due to ...
Cruz-Loya, Mauricio, Lozano-Huntelman, Natalie, Rodríguez-Verdugo, Alejandra, Savage, Van, Yeh, Pamela   +4 more
core   +1 more source

Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates

Cells, 2019
Aggregated forms of the synaptic protein α-synuclein (αS) have been proposed to operate as a molecular trigger for microglial inflammatory processes and neurodegeneration in Parkinson´s disease.
L. Acuña, Sabah Hamadat, Natalia S. Corbalán, F. González-Lizárraga, Maurício dos-Santos-Pereira, Jérémy Rocca, Julia Sepúlveda Díaz, E. Del-Bel, D. Papy-Garcia, R. Chehín, P. Michel, R. Raisman‐Vozari   +11 more
semanticscholar   +1 more source

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin

Acta Medica Indonesiana, 2016
Aim:to determine the effect of a rifampicin-containing tuberculosis regimen on efavirenz plasma concentrations and viral load in HIV/AIDS-Tuberculosis infection patients who received efavirenz-based antiretroviral therapy.
Nina Mariana, Purwantyastuti Purwantyastuti, Instiaty Instiaty, Adria Rusli   +3 more
doaj  

A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis

Lung India, 2015
Background: Lung administration of antibiotics by nebulization is promising for improved treatment efficiency for pulmonary infections, as it increases drug concentration at sites of infection while minimizing systemic side effects.
Jagadevappa S Patil, V Kusum Devi, Kshama Devi, S Sarasija   +3 more
doaj   +1 more source

Virological outcomes of second-line protease inhibitor-based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing-risks prospective cohort analysis [PDF]

, 2017
Background. Second-line antiretroviral therapy (ART) based on ritonavir-boosted protease inhibitors (bPIs) represents the only available option after first-line failure for the majority of individuals living with human immunodeficiency virus (HIV ...
2LADY Study Group, Alexandra Calmy, Anne Derache, ANRS 12249 TasP Study Group, Collins Iwuji, Dami Collier, DART Virology Group and Trial Team, Deenan Pillay, EARNEST Trial Team, Francois Dabis, National Department of Health, National Department of Health, Nonhlanhla Okesola, PharmAccess African Studies to Evaluate Resistance (PASER), PharmAccess African Studies to Evaluate Resistance (PASER), Ravindra K. Gupta, SECOND-LINE, SECOND-LINE Study Group, Southern African Treatment and Resistance Network, TenoRes Study Group, Tulio de Oliveira, World Health Organization, World Health Organization   +22 more
core   +3 more sources

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients

Brazilian Journal of Infectious Diseases
A prospective study was conducted on 79 advanced immunosuppressed AIDS patients from 1997 to 1999, during which nine cases of tuberculosis (TB) were diagnosed.
M.M. O'Donnel, S. Souza Carvalho, A.J. Gadelha, M.G. Morgado, M.C.G. Galhardo, M.C. Lourenço, V.C. Rolla   +6 more
doaj   +1 more source

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

Cochrane Database of Systematic Reviews, 2017
Background Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016 ...

semanticscholar   +1 more source

Detection of multidrug resistant Mycobacterium tuberculosis in Tabuk, Saudi Arabia, using Genotype MTBDRplus

International Journal of Mycobacteriology, 2019
Background: The global increase in the rates of multidrug-resistant (MDR) tuberculosis (TB) has made the timely identification of resistant Mycobacterium tuberculosis complex strains an important emergence to achieve effective disease management and to ...
Eltayib Hassan Ahmed-Abakur, Tarig Mohammed Saad Alnour   +1 more
doaj   +1 more source